These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

354 related items for PubMed ID: 36531464

  • 1. Final adult height in children with central precocious puberty - a retrospective study.
    Knific T, Lazarevič M, Žibert J, Obolnar N, Aleksovska N, Šuput Omladič J, Battelino T, Avbelj Stefanija M.
    Front Endocrinol (Lausanne); 2022; 13():1008474. PubMed ID: 36531464
    [Abstract] [Full Text] [Related]

  • 2. Improved final predicted height with the injection of leuprolide in children with earlier puberty: A retrospective cohort study.
    Lin YC, Lin CY, Chee SY, Yen HR, Tsai FJ, Chen CY, Wang CH.
    PLoS One; 2017; 12(10):e0185080. PubMed ID: 28973010
    [Abstract] [Full Text] [Related]

  • 3. Adult height, body mass index and time of menarche of girls with idiopathic central precocious puberty after gonadotropin-releasing hormone analogue treatment.
    Poomthavorn P, Suphasit R, Mahachoklertwattana P.
    Gynecol Endocrinol; 2011 Aug; 27(8):524-8. PubMed ID: 21501002
    [Abstract] [Full Text] [Related]

  • 4. Development and validation of a model for predicting the adult height of girls with idiopathic central precocious puberty.
    Wu W, Zhu X, Chen Y, Yang X, Zhang Y, Chen R.
    Eur J Pediatr; 2023 Apr; 182(4):1627-1635. PubMed ID: 36708384
    [Abstract] [Full Text] [Related]

  • 5. Which parameters predict the beneficial effect of GnRHa treatment on height in girls with central precocious puberty?
    Vuralli D, Gonc NE, Ozon ZA, Kandemir N, Alikasifoglu A.
    Clin Endocrinol (Oxf); 2021 May; 94(5):804-810. PubMed ID: 33460480
    [Abstract] [Full Text] [Related]

  • 6. The impact of BMI on long-term anthropometric and metabolic outcomes in girls with idiopathic central precocious puberty treated with GnRHas.
    Bruzzi P, Valeri L, Sandoni M, Madeo SF, Predieri B, Lucaccioni L, Iughetti L.
    Front Endocrinol (Lausanne); 2022 May; 13():1006680. PubMed ID: 36263328
    [Abstract] [Full Text] [Related]

  • 7. Near final adult height, and body mass index in overweight/obese and normal-weight children with idiopathic central precocious puberty and treated with gonadotropin-releasing hormone analogs.
    Sinthuprasith P, Dejkhamron P, Wejaphikul K, Unachak K.
    J Pediatr Endocrinol Metab; 2019 Dec 18; 32(12):1369-1375. PubMed ID: 31605579
    [Abstract] [Full Text] [Related]

  • 8. Longitudinal assessment of auxological parameters, adult height outcome and its determinants in leuprolide-treated Indian girls with idiopathic central precocious puberty.
    Mondkar S, Khadilkar V, Yewale S, Dange N, More C, Khadilkar A.
    J Pediatr Endocrinol Metab; 2024 Jan 29; 37(1):62-68. PubMed ID: 38008794
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Long-term observation of 87 girls with idiopathic central precocious puberty treated with gonadotropin-releasing hormone analogs: impact on adult height, body mass index, bone mineral content, and reproductive function.
    Pasquino AM, Pucarelli I, Accardo F, Demiraj V, Segni M, Di Nardo R.
    J Clin Endocrinol Metab; 2008 Jan 29; 93(1):190-5. PubMed ID: 17940112
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Accelerated versus slowly progressive forms of puberty in girls with precocious and early puberty. Gonadotropin suppressive effect and final height obtained with two different analogs.
    Lanes R, Soros A, Jakubowicz S.
    J Pediatr Endocrinol Metab; 2004 May 29; 17(5):759-66. PubMed ID: 15237711
    [Abstract] [Full Text] [Related]

  • 13. Effect of gonadotropin-releasing hormone analog on ovarian reserve in children with central precocious puberty.
    Tao Y, Si C, Li H, Han J, Hou H, Yang M.
    Ann Palliat Med; 2020 Jan 29; 9(1):53-62. PubMed ID: 32005063
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effect of gonadotropin-releasing hormone agonist treatment in boys with central precocious puberty: final height results.
    Mul D, Bertelloni S, Carel JC, Saggese G, Chaussain JL, Oostdijk W.
    Horm Res; 2002 Jan 29; 58(1):1-7. PubMed ID: 12169774
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Efficacy and safety of domestic leuprorelin in girls with idiopathic central precocious puberty: a multicenter, randomized, parallel, controlled trial.
    Li WJ, Gong CX, Guo MJ, Xing J, Li T, Song WH, Luo XP, Wu D, Liang JP, Cao BY, Gu Y, Su C, Liang XJ, Liu M, Wang R, Li FT.
    Chin Med J (Engl); 2015 May 20; 128(10):1314-20. PubMed ID: 25963350
    [Abstract] [Full Text] [Related]

  • 20. Gonadotropin-releasing hormone analogue and recombinant human growth hormone treatment for idiopathic central precocious puberty in girls.
    Shi Y, Ma Z, Yang X, Ying Y, Luo X, Hou L.
    Front Endocrinol (Lausanne); 2022 May 20; 13():1085385. PubMed ID: 36589818
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.